{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:13:12Z","timestamp":1786986792742,"version":"build-2736575974"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cjca.2019.11.012","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T11:43:25Z","timestamp":1574250205000},"page":"234-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapies for Advanced Heart Failure Patients Ineligible for Heart Transplantation: Beyond Pharmacotherapy"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3853-537X","authenticated-orcid":false,"given":"Ashlay A.","family":"Huitema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Harkness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1604-2013","authenticated-orcid":false,"given":"Shiraz","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville","family":"Suskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"McKelvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.11.012_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ehf2.12005","article-title":"Heart failure: preventing disease and death worldwide","volume":"1","author":"Ponikowski","year":"2014","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib2","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.11.012_bib3","first-page":"352","article-title":"Assessing the burden of hospitalized and community-care heart failure in Canada","volume":"30","author":"Blais","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib4","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/CIR.0b013e31824f2173","article-title":"Decision making in advanced heart failure: a scientific statement from the American Heart Association","volume":"125","author":"Allen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.11.012_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1234","article-title":"Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis","volume":"20","author":"Komajda","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"9744","key":"10.1016\/j.cjca.2019.11.012_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2019.11.012_bib9","first-page":"1","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/eurjhf\/hfp041","article-title":"Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology","volume":"11","author":"Jaarsma","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.hfc.2017.02.011","article-title":"Cardiac resynchronization therapy in older adults with heart failure","volume":"13","author":"Lam","year":"2017","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cjca.2019.11.012_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/clc.22124","article-title":"Heart transplantation and left ventricular assist device therapy: two comparable options in end-stage heart failure?","volume":"36","author":"Garbade","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4070\/kcj.2018.0189","article-title":"The past, present and future of heart transplantation","volume":"48","author":"Kim","year":"2018","journal-title":"Korean Circ J"},{"key":"10.1016\/j.cjca.2019.11.012_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.21037\/acs.2017.09.09","article-title":"Donor selection in the modern era","volume":"7","author":"Khush","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2019.11.012_bib16","first-page":"1342","article-title":"2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib17","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.11.012_bib19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jacc.2017.07.735","article-title":"How medicine has changed the end of life for patients with cardiovascular disease","volume":"70","author":"Warraich","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10741-017-9604-9","article-title":"Primary palliative care for heart failure: what is it? How do we implement it?","volume":"22","author":"Gelfman","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2019.11.012_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2174\/1573403X14666180123165203","article-title":"It\u2019s time to talk: challenges in providing integrated palliative care in advanced congestive heart failure. A narrative review","volume":"14","author":"Chow","year":"2018","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.cjca.2019.11.012_bib22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ejhf.151","article-title":"Effects of person-centred and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study","volume":"16","author":"Br\u00e4nnstr\u00f6m","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/jpm.2014.0192","article-title":"Inpatient Palliative care for patients with acute heart failure: outcomes from a randomized trial","volume":"18","author":"Sidebottom","year":"2015","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/heartjnl-2015-308638","article-title":"Effects of a transitional palliative care model on patients with end-stage heart failure: a randomised controlled trial","volume":"102","author":"Wong","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2019.11.012_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacc.2017.05.030","article-title":"Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial","volume":"70","author":"Rogers","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib26","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.jacc.2017.08.036","article-title":"Palliative care in heart failure: rationale, evidence, and future priorities","volume":"70","author":"Kavalieratos","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib27","first-page":"1114","article-title":"The emerging role of palliative care in the management of canadians with heart failure","volume":"34","author":"Rush","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib28","first-page":"1215","article-title":"Patterns of care during the terminal hospital admission for patients with advanced heart failure: a retrospective cohort study","volume":"34","author":"Nazim","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib30","first-page":"863","article-title":"The spoke-hub-and-node model of integrated heart failure care","volume":"34","author":"Huitema","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib31","first-page":"871","article-title":"Heart failure management in nursing homes: a scoping literature review","volume":"34","author":"Heckman","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib32","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/eurjhf\/hfq114","article-title":"Quality of life in patients with chronic heart failure and their carers: a 3-year follow-up study assessing hospitalization and mortality","volume":"12","author":"Iqbal","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12904-016-0074-y","article-title":"\u201cSometimes we can\u2019t fix things\u201d: a qualitative study of health care professionals\u2019 perceptions of end of life care for patients with heart failure","volume":"15","author":"Glogowska","year":"2016","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.cjca.2019.11.012_bib34","first-page":"261","article-title":"Contemporary approaches to patients with heart failure","volume":"35","author":"Mitter","year":"2017","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.cjca.2019.11.012_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S0959259814000136","article-title":"The journey of the frail older adult with heart failure: implications for management and health care systems","volume":"24","author":"Heckman","year":"2014","journal-title":"Rev Clin Gerontol"},{"issue":"Suppl 1","key":"10.1016\/j.cjca.2019.11.012_bib36","first-page":"S101","article-title":"The last six months of life for patients with congestive heart failure","volume":"48","author":"Levenson","year":"2000","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.cjca.2019.11.012_bib37","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/j.jacc.2015.04.052","article-title":"Heart failure as a newly approved diagnosis for cardiac rehabilitation challenges and opportunities","volume":"65","author":"Forman","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib38","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O\u2019Connor","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2019.11.012_bib39","article-title":"Exercise-based cardiac rehabilitation for adults with heart failure","volume":"1","author":"Long","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2019.11.012_bib40","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jacc.2018.12.072","article-title":"Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis","volume":"73","author":"Taylor","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jep.12629","article-title":"Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review","volume":"23","author":"Bohannon","year":"2017","journal-title":"J\u00a0Eval Clin Pract"},{"key":"10.1016\/j.cjca.2019.11.012_bib42","author":"Rector"},{"key":"10.1016\/j.cjca.2019.11.012_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23660","article-title":"Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis","volume":"23","author":"Taylor","year":"2019","journal-title":"Health Technol Assess (Rockv)"},{"issue":"4 Suppl","key":"10.1016\/j.cjca.2019.11.012_bib44","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.ahj.2009.07.012","article-title":"Baseline differences in the HF-ACTION trial by sex","volume":"158","author":"Pina","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2019.11.012_bib45","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib46","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.11.012_bib47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mayocp.2015.10.021","article-title":"Cardiac rehabilitation program adherence and functional capacity among women: a randomized controlled trial","volume":"91","author":"Grace","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2019.11.012_bib48","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/2047487314520783","article-title":"Sex bias in referral of women to outpatient cardiac rehabilitation? A meta-analysis","volume":"22","author":"Colella","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib49","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1177\/2047487319833507","article-title":"The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: a decision model\u2013based analysis","volume":"26","author":"Taylor","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib50","first-page":"260","article-title":"Cardiac rehabilitation models around the globe","volume":"7","author":"Lima de Melo Ghisi","year":"2018","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib51","first-page":"S358","article-title":"Ensuring cardiac rehabilitation access for the majority of those in need: a call to action for Canada","volume":"32","author":"Grace","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib52","first-page":"192","article-title":"Systematizing inpatient referral to cardiac rehabilitation 2010: Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society joint position paper","volume":"27","author":"Grace","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib53","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.pcad.2013.09.010","article-title":"Cardiac rehabilitation series: Canada","volume":"56","author":"Grace","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2019.11.012_bib54","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijcard.2011.01.079","article-title":"Cardiac resynchronization therapy in the elderly: a realistic option for an increasing population?","volume":"155","author":"Ant\u00f3nio","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib56","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib57","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.hrthm.2014.11.014","article-title":"The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study","volume":"12","author":"Gold","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2019.11.012_bib58","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.jacc.2010.12.041","article-title":"Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial\u2014Cardiac Resynchronization Therapy)","volume":"57","author":"Barsheshet","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib59","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.hrthm.2011.04.015","article-title":"Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival","volume":"8","author":"Hayes","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2019.11.012_bib60","first-page":"1539","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib61","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib62","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejheart.2008.01.006","article-title":"Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy","volume":"10","author":"Fantoni","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib63","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2215\/CJN.09120815","article-title":"Cardiorenal resynchronization therapy: strengthening the heart and kidneys","volume":"10","author":"Obeng-Gyimah","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.11.012_bib64","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.2215\/CJN.00620115","article-title":"Cardiac resynchronization therapy in CKD stage 4 patients","volume":"10","author":"H\u00f6ke","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.11.012_bib65","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/CIRCEP.112.973776","article-title":"Reasons for loss of cardiac resynchronization therapy pacing","volume":"5","author":"Cheng","year":"2012","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCHEARTFAILURE.115.002324","article-title":"Comparative effectiveness of cardiac resynchronization therapy among patients with heart failure and atrial fibrillation","volume":"9","author":"Khazanie","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib67","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2008.06.043","article-title":"Cardiac resynchronization in patients with atrial fibrillation. a meta-analysis of prospective cohort studies","volume":"52","author":"Upadhyay","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib68","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10741-018-9732-x","article-title":"Electrical manipulation of the failing heart","volume":"23","author":"Zaca","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2019.11.012_bib69","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jacc.2011.10.891","article-title":"Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure: a systematic review","volume":"59","author":"Ganesan","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib70","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","article-title":"Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and nonischaemic dilated cardiomyopathy","volume":"97","author":"Rossi","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2019.11.012_bib71","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","article-title":"Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment","volume":"103","author":"Grigioni","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.11.012_bib72","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib73","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jacc.2013.02.094","article-title":"Percutaneous mitral valve interventions in the real world","volume":"62","author":"Maisano","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib74","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehv627","article-title":"One-year outcomes and predictors of mortality after Mitraclip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry","volume":"37","author":"Puls","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.11.012_bib75","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2014.06.1166","article-title":"Percutaneous mitral valve edge-to-edge repair","volume":"64","author":"Nickenig","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib76","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib77","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines on the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.11.012_bib78","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib79","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib80","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jacc.2019.02.010","article-title":"Health status after transcatheter mitral-valve repair in heart failure and secondary mitral regurgitation: COAPT trial","volume":"73","author":"Arnold","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/heartasia-2018-011150","article-title":"Nine contemporary therapeutic directions in heart failure","volume":"11","author":"Almarzooq","year":"2019","journal-title":"Heart Asia"},{"key":"10.1016\/j.cjca.2019.11.012_bib82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehx402","article-title":"Refining the prognostic impact of functional mitral regurgitation in chronic heart failure","volume":"39","author":"Goliasch","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.11.012_bib83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcvm.2019.00088","article-title":"Percutaneous mitral valve interventions (repair): current indications and future perspectives","volume":"6","author":"Shah","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.15420\/icr.2018.40.1","article-title":"Why did COAPT Win while MITRA-FR failed? Defining the appropriate patient population for Mitraclip","volume":"14","author":"Atianzar","year":"2019","journal-title":"Interv Cardiol Rev"},{"key":"10.1016\/j.cjca.2019.11.012_bib85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijcha.2018.11.003","article-title":"Futile MITRA-FR and a positive COAPT trial: where does the evidence leave the clinicians?","volume":"22","author":"Arora","year":"2019","journal-title":"IJC Heart Vasc"},{"key":"10.1016\/j.cjca.2019.11.012_bib86","author":"Anker"},{"key":"10.1016\/j.cjca.2019.11.012_bib87","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMe0910394","article-title":"Rise of the machines\u2014left ventricular assist devices as permanent therapy for advanced heart failure","volume":"361","author":"Fang","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib88","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1111\/ajt.14403","article-title":"Mechanical circulatory support in the treatment of advanced heart failure","volume":"17","author":"Cai","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cjca.2019.11.012_bib89","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device","volume":"345","author":"Rose","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib90","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2007.03.063","article-title":"Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates. Results of the INTREPID trial","volume":"50","author":"Rogers","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib91","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2009.03.055","article-title":"Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device","volume":"54","author":"Pagani","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib92","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib93","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa1602954","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib94","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jchf.2018.05.012","article-title":"HVAD: the ENDURANCE supplemental trial","volume":"6","author":"Milano","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib96","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJMoa1800866","article-title":"Two-year outcomes with a magnetically levitated cardiac pump in heart failure","volume":"378","author":"Mehra","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.11.012_bib97","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3325\/cmj.2014.55.577","article-title":"Current state-of-the-art of device therapy for advanced heart failure","volume":"55","author":"Lee","year":"2014","journal-title":"Croat Med J"},{"key":"10.1016\/j.cjca.2019.11.012_bib98","article-title":"Addendum: Ontario clinical guidelines: ventricular assist devices for destination therapy","year":"2017","journal-title":"AddendumOntario Clinical Guidelines Ventricular Assist Devices for Destination Therapy"},{"key":"10.1016\/j.cjca.2019.11.012_bib99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/cer.15.50","article-title":"Cost-effectiveness thresholds in the USA: are they coming? Are they already here?","volume":"5","author":"Dubois","year":"2016","journal-title":"J\u00a0Comp Eff Res"},{"key":"10.1016\/j.cjca.2019.11.012_bib100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCHEARTFAILURE.111.962951","article-title":"Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy","volume":"5","author":"Rogers","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib101","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCHEARTFAILURE.113.000807","article-title":"Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure","volume":"7","author":"Long","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ehf2.12194","article-title":"Cost-effectiveness of left ventricular assist devices for patients with end-stage heart failure: analysis of the French hospital discharge database","volume":"5","author":"Tadmouri","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib103","first-page":"1283","article-title":"Cost effectiveness of continuous flow left ventricular assist devices for destination therapy in end stage heart failure patients ineligible for cardiac transplantation","volume":"33","author":"Chew","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.11.012_bib104","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jchf.2016.09.008","article-title":"Cost-effectiveness of left ventricular assist devices in ambulatory patients with advanced heart failure","volume":"5","author":"Baras Shreibati","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S0266462313000238","article-title":"Cost-effectiveness of continuous-flow left ventricular assist devices","volume":"29","author":"Neyt","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.cjca.2019.11.012_bib106","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/CIRCULATIONAHA.118.035722","article-title":"Healthcare resource use and cost implications in the MOMENTUM 3 long-term outcome study randomized controlled trial of a magnetically levitated cardiac pump in advanced heart failure","volume":"138","author":"Mehra","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cjca.2019.11.012_bib107","first-page":"1","article-title":"Left ventricular assist devices for destination therapy: a health technology assessment","volume":"16","year":"2017","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.cjca.2019.11.012_bib108","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.healun.2006.03.010","article-title":"Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era","volume":"25","author":"Miller","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2019.11.012_bib109","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1510\/icvts.2008.187377","article-title":"Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy","volume":"8","author":"Murray","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.cjca.2019.11.012_bib110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cardfail.2015.10.016","article-title":"Impact of annual hospital volume on outcomes after left ventricular assist device (LVAD) implantation in the contemporary era","volume":"22","author":"Shah","year":"2016","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2019.11.012_bib111","article-title":"CorHealth Ontario. Recommendations to Support Ventricular Assist Device as Destination Therapy in Ontario","year":"2019","journal-title":"Comprehensive report"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19314370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19314370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:42:05Z","timestamp":1760107325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19314370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0828282X19314370"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.11.012","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapies for Advanced Heart Failure Patients Ineligible for Heart Transplantation: Beyond Pharmacotherapy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}